A novel biomarker associated with EBV infection improves response prediction of immunotherapy in gastric cancer

Novel biomarkers are required in gastric cancer (GC) treated by immunotherapy. Epstein-Barr virus (EBV) infection induces an immune-active tumor microenvironment, while its association with immunotherapy respo...
Source: Journal of Translational Medicine - Category: Research Authors: Tags: Research Source Type: research